Trials / Completed
CompletedNCT01665157
Efficacy and Acceptability of Low-Residue Diet Package (Enimaclin®) as Diet Control Before Colonoscopy
A Randomized, Single-blinded, Comparative Study to Evaluate the Efficacy and the Acceptability of Low-residue Diet Package (Enimaclin®) as Diet Control Before Colonoscopy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 180 (actual)
- Sponsor
- National Taiwan University Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and the acceptability of low-residue diet package (Enimaclin®) as diet control before colonoscopy.
Detailed description
In this study, we investigate a randomized, single-blinded, comparative study to evaluate the efficacy and the acceptability of low-residue diet package (Enimaclin®) as diet control before colonoscopy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Enimaclin® | Enimaclin Colomil ® (Glico Co., Japan Osaka),a low-residue diet package for each meal. The duration of study is one day before colonoscopy. |
| OTHER | Self-controlled diet | Self-controlled low residue diet. |
| DRUG | 2L PEG-ELS | Normal volume of PEG-ELS |
| DRUG | low volume 1.5L PEG-ELS | Low volume PEG-ELS |
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2012-06-01
- Completion
- 2012-06-01
- First posted
- 2012-08-15
- Last updated
- 2014-04-02
- Results posted
- 2014-02-06
Locations
4 sites across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT01665157. Inclusion in this directory is not an endorsement.